Capacity of US labs to provide TLI in support of early HIV-1 intervention
| Autor: | Gerber Ar, Thomas L. Hearn, G D Cross, Robert Schwartz, Ronald O. Valdiserri |
|---|---|
| Rok vydání: | 1991 |
| Předmět: |
Gerontology
Acquired Immunodeficiency Syndrome medicine.medical_specialty Referral business.industry Public health Public sector Public Health Environmental and Occupational Health Human immunodeficiency virus (HIV) medicine.disease_cause medicine.disease United States Immunophenotyping Test (assessment) Intervention (law) Acquired immunodeficiency syndrome (AIDS) Family medicine CD4 Antigens HIV-1 Humans Medicine Laboratories business Research Article |
| Zdroj: | American Journal of Public Health. 81:491-494 |
| ISSN: | 1541-0048 0090-0036 |
| DOI: | 10.2105/ajph.81.4.491 |
| Popis: | We surveyed laboratories to assess their capacity to perform T-lymphocyte immunophenotyping. Of the 1026 respondents, 279 located in 41 states and the District of Columbia performed this type of testing. Most laboratories were located in hospitals, reported a low weekly test volume, and indicated that it took 6-24 weeks for flow cytometer operators to become proficient. Many laboratories appear to have the capacity to perform additional CD4+ cell testing, but training additional operators may be necessary. The paucity of laboratories performing T-lymphocyte immunophenotyping in the public sector may affect referral patterns from that setting. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|